rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul Kim

CFO and Treasurer

Company insider

Files Form 4 as: CFO and Treasurer, Fulgent Genetics; Director, Exagen; Chief Financial Officer, Cogent.

In numbers

Trades disclosed
421
Buys
1
Sells
59
Bought
$1.6M
Sold
$24.5M
Companies
3
Companies where not an officer
1
First trade
15 Aug 2007
Last trade
1 Sep 2026
Last filed
3 Sep 2026

Companies traded

Where they are an officer
FLGT Fulgent GeneticsOfficer · Diagnostics & Labs · last 1 Sep 20261 buy · 47 sells
CogentOfficer · last 25 Oct 20100 buys · 12 sells
Everywhere else they filed: board seats, 10% stakes, other companies
XGN ExagenDirector · Diagnostics & Labs · last 9 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Sep 2026filed 3 Sep 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$41K2,087 at $19.59filing
1 Sep 2026filed 3 Sep 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$41K2,087 at $19.59filing
26 Aug 2026filed 28 Aug 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$23K1,168 at $19.81filing
26 Aug 2026filed 28 Aug 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$23K1,168 at $19.81filing
26 Jul 2026filed 28 Jul 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$54K2,747 at $19.67filing
26 Jul 2026filed 28 Jul 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$54K2,747 at $19.67filing
9 Jun 2026filed 19 Aug 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
9 Jun 2026filed 19 Aug 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
1 Jun 2026filed 3 Jun 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$38K2,087 at $18.09filing
1 Jun 2026filed 3 Jun 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$38K2,087 at $18.09filing
26 May 2026filed 28 May 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$21K1,168 at $17.67filing
26 May 2026filed 28 May 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$21K1,168 at $17.67filing
26 Apr 2026filed 28 Apr 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$45K2,747 at $16.31filing
26 Apr 2026filed 28 Apr 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$45K2,747 at $16.31filing
1 Mar 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$17K1,133 at $15.33filing
1 Mar 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$128K8,347 at $15.33filing
1 Mar 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$17K1,133 at $15.33filing
1 Mar 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$128K8,347 at $15.33filing
26 Feb 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$29K1,168 at $24.76filing
26 Feb 2026filed 2 Mar 2026FLGT Fulgent GeneticsDiagnostics & LabsSEC FORM 4 Code F$29K1,168 at $24.76filing

News

Comparing Fulgent Genetics (NASDAQ:FLGT) & Agilon Health (NYSE:AGL)FLGT · themarketsdaily.com · 22 Oct 2026Analyzing Agilon Health (NYSE:AGL) and Fulgent Genetics (NASDAQ:FLGT)FLGT · tickerreport.com · 15 Oct 2026

0 headlines in the last 90 days name Paul Kim; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care48
Not placed12

Buys in green, sells in red, by the company’s sector.

Related people

Ming HsiehDirector · Chief Executive Officer at Fulgent Genetics, filing Form 4 there in the last year
Hanlin GaoChief Scientific Officer · Chief Scientific Officer at Fulgent Genetics, filing Form 4 there in the last year
Jian XiePresident and COO · President and COO at Fulgent Genetics, filing Form 4 there in the last year
Regina E. GrovesDirector · Director at Fulgent Genetics, filing Form 4 there in the last year
Linda DongDirector · Director at Fulgent Genetics, filing Form 4 there in the last year